Grand Pharmaceutical Group Valuation
Is 512 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 512 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 512 (HK$3.64) wird unter unserer Schätzung des Fair Value (HK$18.04) gehandelt.
Deutlich unter dem Marktwert: 512 wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 512?
Other financial metrics that can be useful for relative valuation.
What is 512's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | HK$13.45b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.3x |
Enterprise Value/EBITDA | 4.6x |
PEG Ratio | 0.4x |
Price to Earnings Ratio vs Peers
How does 512's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 7.4x | ||
2096 Simcere Pharmaceutical Group | 4.1x | -28.0% | HK$13.9b |
2005 SSY Group | 10.9x | 15.0% | HK$14.4b |
6600 SciClone Pharmaceuticals (Holdings) | 9x | 4.7% | HK$10.9b |
3933 United Laboratories International Holdings | 5.7x | -2.0% | HK$16.7b |
512 Grand Pharmaceutical Group | 7.2x | 20.0% | HK$13.4b |
Price-To-Earnings gegen Gleichaltrige: 512 ist ein guter Wert, wenn man sein Price-To-Earnings Verhältnis (7.2x) mit dem Durchschnitt der anderen Unternehmen (7.4x) vergleicht.
Price to Earnings Ratio vs Industry
How does 512's PE Ratio compare vs other companies in the HK Pharmaceuticals Industry?
Price-To-Earnings gegen Industrie: 512 ist aufgrund seines Price-To-Earnings Verhältnisses (7.7x) im Vergleich zum Hong Kong Pharmaceuticals Branchendurchschnitt (7.8x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is 512's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 7.2x |
Fair PE Ratio | 11.7x |
PM vs. Fair Ratio: 512 ist ein guter Wert auf der Grundlage des Verhältnisses Price-To-Earnings (5.3x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Earnings (9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.